HCTI Healthcare Triangle, Inc.
Services-Computer Integrated Systems Design · Nasdaq · SEC CIK 1839285 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY141.9%
TTM net income YoY-179.2%
TTM EPS YoY112.9%
Revenue 3-yr CAGR-5.8%
Net income 3-yr CAGR—
Margins
Gross margin548.0%
Operating margin-45.2%
Net margin-56.4%
FCF margin—
EBITDA margin-38.6%
Returns
ROE-59.7%
ROA-40.8%
ROIC (approx.)-32.6%
Asset turnover0.72x
Leverage & solvency
Liabilities / assets30.9%
Debt / equity0.26x
Current ratio0.62x
Interest coverage-40.05x
Cash quality & payout
Operating cash flow / net income0.97x
Accruals ratio-1.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $13.89M | $11.70M | $33.20M | $45.89M | $35.27M |
| Cost of revenue | $12.00M | $8.81M | $26.43M | $34.59M | $24.75M |
| Gross profit | $1.24B | $1.07B | $1.07B | $11.29M | $10.52M |
| R&D expense | $536,000 | $429,000 | $799,000 | $8.14M | $5.26M |
| SG&A expense | $7.34M | $3.95M | $5.73M | $5.52M | $0 |
| Operating income | -$9.79M | -$4.75M | -$7.70M | -$16.32M | -$5.36M |
| Interest expense | $567,000 | — | $968,000 | $212,000 | $567,000 |
| Pretax income | -$9.48M | -$5.96M | -$8.65M | -$13.85M | -$5.92M |
| Income tax | — | $12,000 | $35,000 | $506,000 | $24,000 |
| Net income | -$9.48M | -$5.97M | -$8.69M | -$14.36M | -$5.95M |
| EBITDA | -$9.08M | -$3.86M | -$6.13M | -$13.38M | -$3.94M |
| EPS (basic) | -152.30 | -16,909.30 | -2.08 | -3.88 | -0.20 |
| EPS (diluted) | -152.30 | -16,909.30 | -2.08 | -3.88 | -0.20 |
| Weighted avg. shares (diluted) | 61,873 | 353 | 4.18M | 3.70M | 29.43M |
| Banking | |||||
| Net interest income | -$567,000 | -$1.21M | -$968,000 | -$212,000 | -$567,000 |
| Balance sheet | |||||
| Cash & equivalents | $7.62M | $20,000 | $1.23M | $1.34M | $1.77M |
| Receivables | $2.07M | $1.11M | $3.60M | $5.87M | $9.67M |
| Current assets | $13.15M | $1.45M | $5.65M | $8.02M | $11.80M |
| PP&E, net | $5,000 | $12,000 | $44,000 | $80,000 | $74,000 |
| Goodwill | $2.95M | — | — | $1.29M | $1.29M |
| Intangibles | $2.81M | — | $857,000 | $4.08M | $10.46M |
| Total assets | $22.74M | $1.96M | $6.86M | $13.26M | $24.61M |
| Current liabilities | $12.79M | $7.08M | $8.15M | $6.60M | $6.25M |
| Short-term debt | $10.74M | $2.65M | $3.79M | $2.69M | $2.21M |
| Long-term debt | — | — | $888,000 | — | — |
| Total debt | — | — | $4.68M | — | — |
| Total liabilities | $12.79M | $7.08M | $8.25M | $7.22M | $8.48M |
| Shareholders' equity | $9.98M | -$5.11M | $538,000 | $6.04M | $14.24M |
| Net debt | — | — | $3.44M | — | — |
| Shares outstanding | 7,121 | 380 | 4.31M | 4.17M | 35.26M |
| Cash flow statement | |||||
| Operating cash flow | -$16.52M | -$1.08M | -$2.15M | -$5.35M | -$7.11M |
| Capital expenditure | $6,000 | — | $12,000 | $40,000 | — |
| Free cash flow | -$16.53M | — | -$2.16M | -$5.39M | — |
| Investing cash flow | -$1.75M | — | -$12,000 | -$1.13M | -$7.63M |
| Financing cash flow | $25.88M | -$133,000 | $2.06M | $6.06M | $15.11M |
| Depreciation & amortization | $705,000 | $889,000 | $1.57M | $2.94M | $1.42M |
| Stock-based compensation | $451,000 | $87,000 | $166,000 | $257,000 | $52,000 |
| Share buybacks | — | — | — | $141,000 | — |
Free plan shows the latest 5 periods; Pro shows all 6 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.